Improving the Identification of Disease Modification PD Targets and Their Testing in Clinical Trials

Improving the Identification of Disease Modification PD Targets and Their Testing in Clinical Trials

November 21, 2019
November 22, 2019

Contact: 

Carlos Faraco

Contact Email: 

carlos.faraco@nih.gov

Location: 

NSC
Conference Room C
6001 Executive Blvd.
Rockville, MD 20852

Available on Webex

Day 1   (8:00 a.m. - 4:00 p.m.)

Day 2   (8:00 a.m. - 12:00 p.m.)

Event Description: 

This workshop will bring together leaders in the field and a wide range of stakeholders, to discuss the challenges and gaps in disease modification therapy for Parkinson’s. For more than 3 decades, efforts to achieve this goal have fallen short, in spite of ever improving basic science rigor and trial design. NINDS will take the lead in assessing the needs and identifying solutions and priorities. The workshop will include participants from academia, industry, private foundations, and government organizations. The history of disease modification attempts will be discussed, and discussions of the preliminary data requirements, trial designs, and research priorities will be included. Participants from other fields will share their experience and vision. An important focus will be harmonizing efforts and utilizing potential synergies, both among funding organizations and researchers studying similar topics.